RE:RE:RE:New options Just my humble opinion a few things.
Brad Tompson has not been with ONC for over 5 years. Not sure what is being quoted, referred to etc.
Secondly, just like the company using the ATM. The dillution mantra is a red herring.
The only time share count would matter , would be on a buyout.
Regarding our resident fool, proclaiming a delisting?
As discussed.
Oncy would have to trade continuously under $1, for over a month of trading days.
Then they would receive notice of compliance. Giving at that time 90 dats to comply or issue a plan of compliance.
At that point, there is an additional 3 month waiting period.
adding up to close to a year.
Astor even one day, Oncy closes above $1 within all of those warnings, reminders etc. The whole process starts over.
As our simpleton says, just the facts.
i have been around, Oncy did previously trade well under $1. That being around 2017.
They did issue a public notice of compliance.
I spoke with them then I.R. Guy , Michael Moore.
That was long before the presnt dsy MBc FDA meeting, Roche gobblet Panc trial, enforced by CGAR.
The upcoming next arm of trials to start.
" first patient to be enrolled this quarter".
meaning next few weeks.
Mr. Moore explained the process to me. I may be a bit off in the exact time windows.
His bottom line. they would have to trade un- interrupted under $1, for almost a year, to be delisted.
I know Bucky is hard core shorting. He dreams up scenarios, which are easily refuted & claims them to be facts.
My " opinion" onc has a greater chance of being bought out, than delisted.
The science last few months, including the $5 million grant from PanCan, is evidence of that.
The SP goes up & down.
The TSX lost 100 points yesterday.
perhaps thst is ONCs management fault...lol